Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Mar 13, 2024

BUY
$0.76 - $1.19 $10,640 - $16,660
14,000 New
14,000 $12,000
Q3 2023

Nov 03, 2023

BUY
$0.76 - $1.19 $10,640 - $16,660
14,000 New
14,000 $12,000

Others Institutions Holding CRDL

About Cardiol Therapeutics Inc.


  • Ticker CRDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 61,942,500
  • Market Cap $79.9M
  • Description
  • Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...
More about CRDL
Track This Portfolio

Track Moneco Advisors, LLC Portfolio

Follow Moneco Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneco Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneco Advisors, LLC with notifications on news.